Core Viewpoint - ST HuLuWa Pharmaceutical (605199.SH) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following significant corrections to its financial statements, including a nearly 90% reduction in net profit for 2023 [1][3][4]. Financial Performance - The company's 2023 revenue was adjusted from 1.905 billion yuan to 1.795 billion yuan, and the net profit was revised down from 106 million yuan to 10.85 million yuan, a decrease of 89.81% [4]. - For 2024, the company expects a revenue of 1.414 billion yuan, a year-on-year decline of 21.26%, and a net loss of 274 million yuan, a staggering year-on-year drop of 2629.23% [9][10]. Sales and Product Performance - Sales of key products have significantly declined, with core items like "Chuanlian Ning Capsules" and "Fangban Langen Granules" seeing sales drop by 59.10% and 44.10% respectively [10][12]. - The company reported a 33.88% year-on-year decline in total revenue for the first three quarters of 2025, amounting to 683 million yuan, with a net loss of 11.21 million yuan [12]. Management and Governance Issues - The company has faced multiple management changes, including the resignation of its chairman Liu Jingping from the general manager position and subsequent reappointment [8]. - The CSRC's investigation follows previous reprimands from the Shanghai Stock Exchange for failing to disclose performance losses in a timely manner [1][4][7].

中国经济网北京12月29日讯深圳证券交易所近日发布关于对康佳集团股份有限公司及相关当事人的监管 函。经查，康佳集团股份有限公司(简称：深康佳A，000016.SZ)存在以下问题： 公司于2018年5月18日将持股51%的子公司安徽开开视界电子商务有限公司5%股权转让给广东南方爱视 娱乐科技有限公司。上述交易不满足投资收益确认条件，深康佳A2018年半年报中相关披露不准确。 公司的上述行为违反了深圳证券交易所《股票上市规则(2018年修订)》第1.4条、2.1条、第2.5条的规 定。时任董事长刘凤喜、时任总经理周彬、时任财务总监李春雷未能勤勉尽责，对上述相关问题负有主 要责任。 成都商报旗下红星资本局报道《深康佳A和前任董事长收警示函，与7年前一桩股权转让有关，曾遭子 公司股东举报》显示，今年4月，深康佳A突遭子公司股东朱新明实名举报。朱新明当时接受红星资本 局采访时表示，2018年6月，康佳集团出售旗下子公司开开视界5%的股权，接盘方为南方爱视，这笔股 权出售给康佳集团带来5000万元的现金净额。但朱新明称，这笔交易是康佳集团的资金"左手倒右手"， 目的是虚增业绩。对于该举报，今年4月17日，周彬回复红星资本 ...

Core Viewpoint - Beisiqiong, a smart massage device company, has faced significant challenges since its debut on the STAR Market, including a loss in its first year of listing and an ongoing investigation for information disclosure violations involving its actual controller, Ma Xuejun [1][2]. Group 1: Financial Performance - In 2021, Beisiqiong was hailed as the "first stock of health smart hardware" upon its listing, but it recorded a loss of 124 million yuan in 2022, a decline of 235.46% year-on-year [4]. - The company continued to incur losses in 2023, amounting to 50.87 million yuan, but managed to turn a profit in 2024 with a net profit of 10.25 million yuan [4]. - In the first quarter of 2025, Beisiqiong reported a loss of 1.83 million yuan, which expanded to 36.11 million yuan by the end of the first half of the year [5]. - For the first three quarters of 2025, the company achieved a revenue of 552 million yuan, a year-on-year decline of 34.07%, with a net loss of 65.63 million yuan, a staggering drop of 600.98% [5]. Group 2: Regulatory Issues - Beisiqiong has received performance report inquiry letters from the exchange for four consecutive years, indicating ongoing issues with information disclosure related to its business operations, sales expenses, and internal controls [2]. - The 2024 annual report revealed instances of fund occupation and illegal guarantees, with the internal control audit report issued with an emphasis paragraph by the accounting firm [2]. - The company has acknowledged past occurrences of non-operating fund occupation and illegal guarantees, committing to improve internal management and controls [3]. Group 3: Shareholder Actions - Since June 2023, Beisiqiong's stock price has been on a downward trend, prompting several shareholders to announce share reductions [6]. - From June 17 to July 10, 2023, the employee shareholding platform, Ningbo Beisong Investment Co., Ltd., reduced its holdings by 1.43%, totaling 37.64 million yuan [6]. - On November 20, 2023, Ma Xuejun sold 2.97% of his shares for 64.71 million yuan, reducing his ownership from 40.48% to 37.51% [6].

中国经济网北京12月29日讯中国证监会安徽监管局近日下发《关于对合肥高科科技股份有限公司及相关 人员采取出具警示函措施的决定》(中国证券监督管理委员会安徽监管局行政监管措施决定书〔2025〕 80号)。 经查，安徽证监局发现合肥高科科技股份有限公司(以下简称"合肥高科"，920718.BJ)存在以下问题：一 是公司开立募集资金专户未经董事会审议与批准，公司在临时报告中披露的内容与以上事实不符，信息 披露不准确；二是公司《募集资金管理制度》未明确责任追究内部制度、风险防控措施等内容。上述行 为违反了《上市公司信息披露管理办法》(证监会令第182号，以下简称《信披管理办法》)第三条第一 款、《北京证券交易所上市公司持续监管办法(试行)》(证监会令第189号，以下简称《北交所持续监管 办法》)第八条和第十条相关规定。 合肥高科董事长胡翔、董事会秘书汪晓志，对合肥高科上述行为负有主要责任。 合肥高科于2022年12月22日在北交所上市，发行数量为2,266.67万股(不含超额配售选择权)；2,606.67万 股(全额行使超额配售选择权后)，发行价为6.50元/股，保荐机构为国元证券股份有限公司，签字保荐代 表人为王健 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、因信披违规被立案 12月26日，臻镭科技（维权）发布公告，收到中国证监会下发的《立案告知书》。因公司涉嫌信息披露 违法违规，根据相关法律法规，中国证监会决定对该公司进行立案。 就在立案前一天，公司刚披露一则会计差错公告，其相关财报存在问题需进行更正，立案或与该事项有 关。 该消息一经披露，立即在资本市场引发震动。此前不久的9月，该公司实际控制人、董事长郁发新已被 黄石市监察委员会实施留置措施，其控制的企业也在被留置前完成了一笔高达4.44亿元的减持套现。 上海沪紫律师事务所刘鹏律师表示监管部门对信息披露违规行为的打击力度正在加强，受损股民可积极 参与维权挽回损失。 符合于2025年12月26日（含当日）之前买入，并在2025年12月27日之后卖出或仍持有而亏损即可加 入索赔。（臻镭科技维权入口） 二、相关财报存在问题 在收到《立案告知书》的前一 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、信披违规被立案 12月26日ST长园（维权）发布公告，因涉嫌信息披露违法违规被中国证监会立案调查。一张证监会立 案告知书在年末送达，让这家已戴上ST帽子的上市公司股价再度蒙上阴影，投资者们翻开公司公告， 发现这并非它第一次出现"问题"。 （本文由上海沪紫律师事务所刘鹏律师供稿，不代表新浪财经的观点。刘鹏律师，专注证券维权19年， 自2006年执业以来，成功为中青宝、国华网安、劲嘉股份（维权）等 300 余家上市公司的中小投资者成 功维权，案件在办数量超过 14000 起，胜诉率达 99.2%。作为业内资深证券维权律师，刘鹏律师精准把 握案件核心，诉讼经验丰富，索赔策略高效，为投资者争取最大权益，维权实力行业领先。证券维权， 选对律师是关键！专业决定胜算，经验确保结果，首选刘鹏律师，让您的索赔更稳妥、更高效！）（刘 鹏律师专栏） 上海沪紫律师事务 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 在监管关注和公司自查的双重机制下，问题终于浮出水面。尽管派瑞股份在公告中强调，"本次更正不 会导致公司已披露的年度财务报表出现盈亏性质的改变"，但市场反应依然明显。 二、曾进行会计差错 派瑞股份在自查中发现，2024年度一笔销售合同中部分收入存在延期确认的会计处理差错。公司已对相 关定期报告进行会计差错更正及追溯调整，涉及2024年三季度至2025年三季度多个报告期。 具体数据显示，2024年少确认营业收入2271.51万元，相应少确认利润总额1711.73万元。从业绩影响来 看，2024年归母净利润从更正前的5677.52万元调整为7132.49万元；2025年前三季度归母净利润从 2010.96万元调整为555.96万元。 值得关注的是，2025年前三季度公司净利润同比出现大幅下降，2025年三季报净利润为2010.96万元， 较去年同期下降6 ...

Core Viewpoint - The article discusses the undisclosed agreements and potential changes in control at ST Yinjing, highlighting regulatory actions taken against its major shareholder and the implications for corporate governance [2][4][11]. Group 1: Regulatory Actions - On December 16, the Zhejiang Securities Regulatory Bureau and the Shenzhen Stock Exchange issued warning letters to ST Yinjing's major shareholder, Yinjing Group, and its actual controller, Wang Hui, for failing to disclose several agreements related to voting rights and control [2][4]. - The undisclosed agreements include a cooperation framework agreement and a voting rights delegation agreement, which raise questions about potential changes in actual control [2][4]. Group 2: Financial Agreements - Yinjing Group entered into a loan agreement with Shanghai Yuanzhuo, which included a provision for delegating voting rights of 10.3% of ST Yinjing's shares to Shanghai Yuanzhuo in exchange for financial support to resolve fund occupation issues [4][5]. - A subsequent memorandum stipulated that the voting rights would be delegated based on the actual loan amount, with governance structure changes proposed for the board of directors [5][6]. Group 3: Governance and Disclosure Issues - Board member Peng Xiaoyong raised concerns about the board's failure to disclose the agreements, asserting that the actual control of the company is uncertain and should have been communicated to investors [8][9]. - Despite Peng's submission of the undisclosed agreements to the board, ST Yinjing has not yet made this information public, which raises questions about the board's independence and compliance with disclosure obligations [9][11]. Group 4: Board Restructuring - On December 16, ST Yinjing announced a board restructuring process, nominating candidates for the seventh board of directors, despite ongoing disputes regarding control and governance [13][14]. - Board members Peng Xiaoyong and Cai Yang opposed the restructuring, citing the lack of disclosure regarding the voting rights agreements and the potential infringement on the interests of related parties [14][15].

Core Viewpoint - The significant loss of 40 million yuan in a private equity investment by Shengyuan Environmental Protection has raised concerns about the effectiveness of risk control measures and the responsibilities of the fund custodian [1][6]. Group 1: Investment Loss Details - Shengyuan Environmental Protection's subsidiary invested 60 million yuan in the "Deep博宏图成长1号" private equity fund, which saw its net value plummet from 0.9215 yuan to 0.2596 yuan within a week, resulting in a 73% loss [3][4]. - As of December 25, the fund's net value further declined to 0.1846 yuan, with a cumulative loss of approximately 4.692 million yuan, exceeding 10% of the company's audited net profit for the last fiscal year [4][6]. Group 2: Risk Control Measures - The investment agreement included strict disclosure and risk control standards, such as limiting single asset holdings to 25% of the fund's net assets and mandatory disclosures when net values hit certain thresholds [5][6]. - Despite these measures, the fund manager allegedly engaged in unauthorized trading and failed to disclose critical information, leading to significant investor losses [6][9]. Group 3: Regulatory Actions and Responses - Shengyuan Environmental Protection received warning letters from the Xiamen Securities Regulatory Bureau and the Shenzhen Stock Exchange for failing to disclose the significant losses in a timely manner [2][9][10]. - The actual controller of Shengyuan Environmental Protection has committed to compensating the investment losses, amounting to the original investment of 60 million yuan [10].

Core Viewpoint - The article highlights a significant issue regarding undisclosed agreements related to the control and governance of ST Yinjian, raising concerns about potential violations of information disclosure regulations and the implications for corporate governance [1][10]. Group 1: Regulatory Actions - Zhejiang Securities Regulatory Bureau and Shenzhen Stock Exchange issued warning letters to ST Yinjian's controlling shareholder, Yinjian Group, and its actual controller, Wang Hui, for failing to disclose a series of agreements [1]. - The undisclosed agreements include a cooperation framework agreement and a voting rights entrustment agreement, which are critical for understanding the control dynamics of the company [1][6]. Group 2: Shareholder Agreements - Yinjian Group entered into a loan agreement with Shanghai Yuanzhuo, providing up to 200 million yuan to resolve financial issues, in exchange for the voting rights of 10.3% of ST Yinjian's shares [2]. - Subsequently, Yinjian Group allegedly engaged in "double selling" of the same 10.3% stake, promising control to both Shanghai Yuanzhuo and another party, Yao Chengling [3]. Group 3: Governance and Board Dynamics - The board of directors of ST Yinjian was aware of the undisclosed agreements but failed to disclose them, raising questions about their compliance with disclosure obligations [6][8]. - A board meeting on December 15, 2025, was held to elect new board members, despite ongoing disputes regarding control and governance, which some board members opposed [11][13]. Group 4: Dispute Over Board Representation - Board members expressed concerns that the current governance structure and the election of new board members could infringe on the rights of stakeholders involved in the undisclosed agreements [13]. - The board's refusal to acknowledge the nomination rights of certain parties, despite previous recognition, indicates inconsistencies in governance practices [13].